Caring Brands, Inc. (CABR): Entry into a Material Definitive Agreement

Caring Brands, Inc. (CABR) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.1 4 ex10-1.htm EX-10.1 Exhibit 10.1 SECURITIES PURCHASE AGREEMENT THIS SECURITIES PURCHASE AGREEMENT (this “ Agreement ”) is entered into and made effective as of July 10, 2026, by and between Caring Brands, Inc., a Nevada corporation (the “ Company ”), and the purchaser id

Event · Offering · closed
Instrument
Series A Convertible Preferred Stock
Gross proceeds
$400,000
Price per share
$950 per share
Use of proceeds
retire an aggregate of 150,000 shares of the Company’s Common Stock owned by BK Investments LLC
Also in this documentBuyback · 150K

Facts are quoted from the filing text and checked against it.

Original reporting
Published Jul 16, 2026, 9:12 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 16, 2026, 9:14 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$CABR
Bearish
medium confidence
Mentioned
$CABR
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$CABRBearishMed
01

Why it matters

Traders should focus on dilution math (conversion terms and warrant coverage), potential resale/registration timeline, and whether the financing meaningfully extends runway versus being purely financing-driven.

02

Market read

A newly disclosed convertible-and-warrant financing can create immediate valuation pressure and warrant-driven overhang, especially for microcaps.

03

What to watch

Key missing details include the actual number of preferred shares issued, conversion ratio, any discount to market, and whether proceeds are earmarked for specific milestones; these determine real dilution and catalyst value.

Relevance 6/10Novelty 6/10Timing: after-hours filing on 2026-07-16, ahead of any trading reaction to the financing terms

Background

The 8-K reports entry into a material definitive securities purchase agreement, including issuance of Series A convertible preferred stock and warrants, plus an unregistered sales component.

Company-level read

Ticker impact

$CABRBearishMedium confidence
Context

Caring Brands filed an 8-K for a securities purchase agreement, issuing up to $400,000 of Series A convertible preferred and $0.40 5-year warrants.

Expected impact

Near-term downside bias or volatility around dilution expectations; magnitude likely limited given the stated $400,000 maximum.

Evidence & confidence

The article discloses the financing structure (convertible preferred plus warrants) and maximum gross amount, but provides no pricing details beyond the $0.40 warrant exercise price or conversion terms, limiting precision on dilution impact.

Market effects

Microcap financing structures (convertibles plus warrants) can reinforce sector-wide concerns about dilution and capital efficiency.

Limited, primarily affects US microcap sentiment rather than broader regional flows.

Low global relevance; this is company-specific capital raising.

Counterpoint

If the purchaser is a strategic backer and the conversion/warrant terms are favorable to existing holders, the financing could reduce liquidity risk and stabilize the stock.

Key entities

  • Caring Brands, Inc.

    Nevada corporation that entered the securities purchase agreement and will issue Series A convertible preferred stock and warrants.

  • Purchaser (unnamed in excerpt)

    Entity purchasing up to $400,000 of Series A convertible preferred and receiving warrants to acquire additional common shares.

Related articles

$TTRXMedAI 8/10

Top Biotech Gainers: TTRX Turns Heads, LIXT Shifts To AI Energy, CNXU Update, QTRX, TRAX On Watch

Turn Therapeutics (TTRX) rose over 20% after interim Phase 2 results for GX-03 in atopic dermatitis, with 92.6% achieving EASI-50 at 4 weeks. Conexeu (CNXU) gained ~19% on preclinical B.R.E.A.S.T. bioprinting progress. Rallybio (RLYB) jumped on plans to acquire Avenzo via a $215M investment. LIXTE (LIXT) surged on an AI energy pivot; Quanterix (QTRX) rose on insider SEC filing.

$MARAMed

MARA prices $185M debt offering after $1.1B Bitcoin sale

MARA priced an $185M debt offering at 8.75% interest, maturing in 2032, to finance its $1.5B acquisition of Long Ridge Energy. The deal includes a 485MW power plant and land for potential data centers. MARA recently sold $1.1B in Bitcoin to repay debt. Long Ridge generated $144M in annualized adjusted EBITDA, but interest payments may consume nearly half.

$RIOLow

Rio Tinto commits US$250m to address damage from Bougainville's Panguna mine

Rio Tinto will contribute $250m to a fund addressing environmental and human rights impacts of the Panguna mine, per an agreement with Bougainville Copper Limited, the Autonomous Bougainville Government, and community leaders. The fund aims to support practical responses to identified impacts and social projects. Details will be developed in consultation with communities.

$PLCEMed

The Children’s Place begins nationwide closing sales as the future of hundreds of stores remains uncertain

The Children's Place has begun nationwide closing sales across its 500 stores in the U.S. and Canada, following a Chapter 11 bankruptcy filing. The retailer is seeking a buyer to potentially preserve operations. Gymboree, also owned by the company, is included in the liquidation. Sales are ongoing in stores and online, with gift cards and rewards valid until Dec. 12, 2026. The company aims to complete the sale process by the end of December, but the future of stores and brands remains uncertain.

$SNTMed

Insurer Santam Grows 10% as Returns Slip

Santam, a South African insurer, reported 10% growth in premiums for the nine months ending September 2026, but investment returns fell to 2.5% from 3% due to weaker markets. The company's underwriting margin improved since June, staying within its 5%-10% target. Sanlam, which holds 63% of Santam, offered R505 per share to acquire the remaining shares, with the deal expected to close in Q1 2027. Santam's share price is currently 2.8% below the offer price.